eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

CSL Behring UK Limited

Hayworth House, Market Place, Haywards Heath, West Sussex, RH16 1DB, UK
Telephone: +44 (0)1444 447 400
Fax: +44 (0)1444 447 403
WWW: http://www.cslbehring.co.uk
Medical Information Direct Line: +44 (0)1444 447 405
Medical Information e-mail: medinfo@cslbehring.com
Customer Care direct line: +44 (0)1444 447 402
Out of Hours contact: +44 (0)1444 447 405

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 29/07/2010
PIL Haemate P 500 and 1000 IU

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/07/2010 and displayed until Current
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to information for healthcare professionals
  • Change to warnings or special precautions for use
  • Change to storage instructions
Updated on 14/05/2009 and displayed until 29/07/2010
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 07/08/2008 and displayed until 14/05/2009
Reasons for adding or updating:
  • Change to storage instructions
  • Change due to user-testing of patient information
Updated on 11/04/2007 and displayed until 07/08/2008
Reasons for adding or updating:
  • Company name change or merger
Updated on 09/11/2006 and displayed until 11/04/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 23/06/2006 and displayed until 09/11/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   factor VIII
   von willebrand factor